Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aligos Therapeutics Inc (ALGS)

Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,523
  • Shares Outstanding, K 3,196
  • Annual Sales, $ 15,530 K
  • Annual Income, $ -87,680 K
  • EBIT $ -94 M
  • EBITDA $ -91 M
  • 60-Month Beta 2.11
  • Price/Sales 2.01
  • Price/Cash Flow N/A
  • Price/Book 0.46

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 96.68%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -2.15
  • Number of Estimates 3
  • High Estimate 0.45
  • Low Estimate -4.40
  • Prior Year -10.25
  • Growth Rate Est. (year over year) +79.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.76 +40.24%
on 10/08/24
10.39 -8.76%
on 10/30/24
+1.32 (+16.18%)
since 10/04/24
3-Month
6.76 +40.24%
on 10/08/24
19.50 -51.38%
on 09/09/24
-2.65 (-21.81%)
since 08/02/24
52-Week
6.76 +40.24%
on 10/08/24
30.00 -68.40%
on 03/04/24
-9.53 (-50.12%)
since 11/03/23

Most Recent Stories

More News
Aligos Therapeutics to Announce 3rd Quarter 2024 Financial Results on November 6, 2024

ALGS : 9.48 (-0.73%)
Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184

ALGS : 9.48 (-0.73%)
Aligos Therapeutics Announces Acceptance of Abstracts on Incremental Data from ALG-000184 in CHB Subjects and Late-Breaker Oral Presentation of Data from the Phase 2a HERALD Study of ALG-055009 in MASH Subjects at The Liver Meeting (TLM) 2024

ALGS : 9.48 (-0.73%)
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ALGS : 9.48 (-0.73%)
Stocks Set to Open Higher as Investors Await Powell Speech, Debt Ceiling Optimism Lifts Sentiment

June S&P 500 futures (ESM23) are up +0.39%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.32% this morning as market participants awaited an update on plans to raise the U.S. debt ceiling while...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
LNC : 32.91 (-1.82%)
PACW : 7.54 (-2.71%)
FSLR : 212.28 (+3.58%)
CS.P.DX : 34.040 (-0.82%)
NGMS : 29.45 (+0.07%)
MMP : 69.00 (+0.67%)
OKE : 95.64 (+2.44%)
ALGS : 9.48 (-0.73%)
DD : 81.85 (-0.79%)
ALB : 100.57 (+2.37%)
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2022 Financial Results

SOUTH SAN FRANCISCO, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company...

ALGS : 9.48 (-0.73%)
Aligos Therapeutics to Present at the Jefferies 2022 Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company...

ALGS : 9.48 (-0.73%)
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2022 Financial Results

SOUTH SAN FRANCISCO, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company...

ALGS : 9.48 (-0.73%)
Aligos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights

CAM (ALG-000184) continues to demonstrate best in class potential in Phase 1bASO (ALG-020572) completed dosing in Phase 1a (HVs); Phase 1b study (CHB)...

ALGS : 9.48 (-0.73%)
Aligos Therapeutics to Announce Fourth Quarter and Full Year 2021 Results March 10, 2022

SOUTH SAN FRANCISCO, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company...

ALGS : 9.48 (-0.73%)

Business Summary

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company. It is focused on the development of antiviral therapies for chronic hepatitis B and coronaviruses as well as liver diseases. Aligos Therapeutics, Inc. is based in SAN FRANCISCO, Calif.

See More

Key Turning Points

3rd Resistance Point 10.34
2nd Resistance Point 10.11
1st Resistance Point 9.80
Last Price 9.48
1st Support Level 9.26
2nd Support Level 9.03
3rd Support Level 8.72

See More

52-Week High 30.00
Fibonacci 61.8% 21.12
Fibonacci 50% 18.38
Fibonacci 38.2% 15.64
Last Price 9.48
52-Week Low 6.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar